589 related articles for article (PubMed ID: 29282686)
1. Perspectives of Reprogramming Breast Cancer Metabolism.
Wang YP; Lei QY
Adv Exp Med Biol; 2017; 1026():217-232. PubMed ID: 29282686
[TBL] [Abstract][Full Text] [Related]
2. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
Yoshida GJ
J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
[TBL] [Abstract][Full Text] [Related]
3. Cancer Stem Cell-Associated Pathways in the Metabolic Reprogramming of Breast Cancer.
El-Sahli S; Wang L
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266219
[TBL] [Abstract][Full Text] [Related]
4. Metabolic and epigenetic reprogramming in the arsenic-induced cancer stem cells.
Li L; Bi Z; Wadgaonkar P; Lu Y; Zhang Q; Fu Y; Thakur C; Wang L; Chen F
Semin Cancer Biol; 2019 Aug; 57():10-18. PubMed ID: 31009762
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
Martinez-Outschoorn U; Sotgia F; Lisanti MP
Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
[TBL] [Abstract][Full Text] [Related]
6. Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer.
Lao L; Fan S; Song E
Adv Exp Med Biol; 2017; 1026():331-370. PubMed ID: 29282692
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Proteomics Analysis Reveals Metabolic Reprogramming of Tumor-Associated Macrophages Stimulated by the Tumor Microenvironment.
Liu D; Chang C; Lu N; Wang X; Lu Q; Ren X; Ren P; Zhao D; Wang L; Zhu Y; He F; Tang L
J Proteome Res; 2017 Jan; 16(1):288-297. PubMed ID: 27809537
[TBL] [Abstract][Full Text] [Related]
8. The Role of Sodium Hydrogen Exchanger 1 in Dysregulation of Proton Dynamics and Reprogramming of Cancer Metabolism as a Sequela.
Cardone RA; Alfarouk KO; Elliott RL; Alqahtani SS; Ahmed SBM; Aljarbou AN; Greco MR; Cannone S; Reshkin SJ
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357694
[TBL] [Abstract][Full Text] [Related]
9. Metabolic reprogramming of metastatic breast cancer and melanoma by let-7a microRNA.
Serguienko A; Grad I; Wennerstrøm AB; Meza-Zepeda LA; Thiede B; Stratford EW; Myklebost O; Munthe E
Oncotarget; 2015 Feb; 6(4):2451-65. PubMed ID: 25669981
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem cell metabolism: a potential target for cancer therapy.
Deshmukh A; Deshpande K; Arfuso F; Newsholme P; Dharmarajan A
Mol Cancer; 2016 Nov; 15(1):69. PubMed ID: 27825361
[TBL] [Abstract][Full Text] [Related]
11. Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion.
Yan L; Wu M; Wang T; Yuan H; Zhang X; Zhang H; Li T; Pandey V; Han X; Lobie PE; Zhu T
Cancer Res; 2024 Apr; 84(8):1270-1285. PubMed ID: 38335272
[TBL] [Abstract][Full Text] [Related]
12. Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression.
Yang E; Wang X; Gong Z; Yu M; Wu H; Zhang D
Signal Transduct Target Ther; 2020 Oct; 5(1):242. PubMed ID: 33077737
[TBL] [Abstract][Full Text] [Related]
13. Reprogramming of central carbon metabolism in cancer stem cells.
Wong TL; Che N; Ma S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1728-1738. PubMed ID: 28502706
[TBL] [Abstract][Full Text] [Related]
14. Biological role of metabolic reprogramming of cancer cells during epithelial‑mesenchymal transition (Review).
Li M; Bu X; Cai B; Liang P; Li K; Qu X; Shen L
Oncol Rep; 2019 Feb; 41(2):727-741. PubMed ID: 30483813
[TBL] [Abstract][Full Text] [Related]
15. Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment.
Pires BR; DE Amorim ÍS; Souza LD; Rodrigues JA; Mencalha AL
Anticancer Res; 2016 Nov; 36(11):5681-5691. PubMed ID: 27793889
[TBL] [Abstract][Full Text] [Related]
16. Metabolic crosstalk in the breast cancer microenvironment.
Dias AS; Almeida CR; Helguero LA; Duarte IF
Eur J Cancer; 2019 Nov; 121():154-171. PubMed ID: 31581056
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications.
Gandhi N; Das GM
Cells; 2019 Jan; 8(2):. PubMed ID: 30691108
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial OXPHOS Induced by RB1 Deficiency in Breast Cancer: Implications for Anabolic Metabolism, Stemness, and Metastasis.
Zacksenhaus E; Shrestha M; Liu JC; Vorobieva I; Chung PED; Ju Y; Nir U; Jiang Z
Trends Cancer; 2017 Nov; 3(11):768-779. PubMed ID: 29120753
[TBL] [Abstract][Full Text] [Related]
19. Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells.
Lamb R; Ozsvari B; Bonuccelli G; Smith DL; Pestell RG; Martinez-Outschoorn UE; Clarke RB; Sotgia F; Lisanti MP
Oncotarget; 2015 Sep; 6(26):21892-905. PubMed ID: 26323205
[TBL] [Abstract][Full Text] [Related]
20. Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy.
Yan L; Tan Y; Chen G; Fan J; Zhang J
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
